SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-12-191371
Filing Date
2012-04-27
Accepted
2012-04-27 16:45:01
Documents
5
Period of Report
2012-06-22
Effectiveness Date
2012-04-27

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d339604ddef14a.htm DEF 14A 309320
2 GRAPHIC g339604g76d82.jpg GRAPHIC 22437
3 GRAPHIC g339604g95j55.jpg GRAPHIC 8747
4 GRAPHIC g339604pc1.jpg GRAPHIC 166867
5 GRAPHIC g339604pc2.jpg GRAPHIC 71276
  Complete submission text file 0001193125-12-191371.txt   681985
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35420 | Film No.: 12790304
SIC: 2834 Pharmaceutical Preparations